Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Raw Materials: 2022

Historic Raw Materials for Amylyx Pharmaceuticals (AMLX) over the last 1 years, with Dec 2022 value amounting to $7.2 million.

  • Amylyx Pharmaceuticals' Raw Materials was N/A to $7.2 million in Q4 2022 from the same period last year, while for Dec 2022 it was $7.2 million, marking a year-over-year change of. This contributed to the annual value of $7.2 million for FY2022, which is N/A change from last year.
  • According to the latest figures from FY2022, Amylyx Pharmaceuticals' Raw Materials is $7.2 million.
  • In the past 5 years, Amylyx Pharmaceuticals' Raw Materials ranged from a high of $7.2 million in FY2022 and a low of $7.2 million during FY2022.
  • Over the past 1 years, Amylyx Pharmaceuticals' median Raw Materials value was $7.2 million (recorded in 2022), while the average stood at $7.2 million.